It is necessary to explore new effective targets other than VEGF for inhibiting neovascularization caused by diabetic retinopathy, retinopathy of prematurity (ROP) and age-related macular degeneration (AMD). This evidence concerns the gene VEGFA and retinopathy of prematurity.